Search Results - "De Larrañaga, G."

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies by Forastiero, R R, Martinuzzo, M E, de Larrañaga, G F

“…The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In…”
Get full text

Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile by Latino, J O, Udry, S, Aranda, F M, Perés Wingeyer, S D A, Fernández Romero, D S, de Larrañaga, G F

“…Conventional treatment of obstetric antiphospholipid syndrome fails in approximately 20–30% of pregnant women without any clearly identified risk factor. It is…”
Get full text

Heparin-platelet factor 4 induced antibodies in patients with either autoimmune or alloimmune antiphospholipid antibodies by de Larrañaga, G, Martinuzzo, M, Bocassi, A, Fressart, M Migaud, Forastiero, R

Get more information

Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics? by Udry, S., Aranda, F. M., Latino, J. O., Larrañaga, G. F.

“…Summary Background In up to 50% of couples affected by recurrent pregnancy loss, no identifiable cause is established. Fetal and maternal factors may be…”
Get full text

Association between the acquired free protein S deficiency in HIV‐infected patients with the lipid profile levels by De Larrañaga, G., Perés, S., Puga, L., Alonso, B., Benetucci, J.

Get full text

Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?: reply by Udry, S., Aranda, F. M., Latino, J. O., Larrañaga, G. F.

Get full text

Association between severe disease course and nephritis with Q222R polymorphism in DNAse I gene among lupus patients: An Argentine multicenter study by Camicia, G, Muñoz, S A, Allievi, A, Orden, A O, Perés Wingeyer, S, Trobo, R, Eimon, A, Barreira, J C, Schneeberger, E, Sarano, J, Hofman, J, de Larrañaga, G, Aranda, F

“…Objetives: Systemic lupus erythematosus is a multifactorial autoimmune disease and the glomerulonephritis is one of the most severe complications, which leads…”
Get full text

Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: the first case reported by de Larrañaga, G F, Remondino, G I, Forastiero, R R, Cunto, E R, Narbaitz, M, Olenchuk, A B, Zala, N S, Juan, J A San

“…The case of a man with diagnosis of Kikuchi-Fujimoto disease (KFD) and catastrophic antiphospholipid syndrome (CAPS) is reported. He presented prolonged fever,…”
Get full text

Anti‐β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model by FORASTIERO, R., MARTINUZZO, M., DE LARRAÑAGA, G., VEGA‐OSTERTAG, M., PIERANGELI, S.

Get full text

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment by DE LARRANAGA, G. F, PERES WINGEYER, S. D. A, PUGA, L. M, ALONSO, B. S, BENETUCCI, J. A

“…Insulin resistance is associated with highly active antiretroviral therapy in HIV-infected patients, and the risk of developing insulin resistance is increased…”
Get full text

Insulin resistance status is an important determinant of PAI‐1 levels in HIV‐infected patients, independently of the lipid profile by De Larrañaga, G., Galich, A., Puga, L., Alonso, B., Benetucci, J.

Get full text

Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection‐related antiphospholipid antibodies by Forastiero, R. R., Martinuzzo, M. E., De Larrañaga, G., Broze, G. J.

Get full text

High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity by de Larrañaga, G F, Forastiero, R R, Martinuzzo, M E, Carreras, L O, Tsariktsian, G, Sturno, M M, Alonso, B S

“…Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates…”
Get full text

PB0068 Pulmonary Sequelae in Long COVID are not Associated with the Carriage of Prothrombotic Genetic Variants by de Larrañaga, G., Rossi, P., Trullas, F., Brichetti, V., Perés, S., Aranda, F., Montesinos, P., Rubilar, T., Crespi, A., Martinez Fraga, A., Sívori, M., Saldarini, F.

Get full text

PB0061 von Willebrand Factor as a Biomarker of Endothelial Activation/Injury in Long COVID Patients Like What Reported in HIV Patients under Treatment by de Larrañaga, G., Perés, S., Aranda, F., Brichetti, V., Tejada, J., Vázquez, J., Jajati, M., Chamorro, J., Bocassi, A., Rubilar, T., Crespi, A., Sívori, M., Saldarini, F.

Get full text

Different Types of Antiphospholipid Antibodies in AIDS: A Comparison with Syphilis and the Antiphospholipid Syndrome by de Larrañaga, Gabriela F., Forastiero, Ricardo R., Carreras, Luis O., Alonso, Beatriz S.

“…Alloimmune antiphospholipid antibodies react with phospholipids and are an epiphenomenon of an infectious disease. Most autoimmune antiphospholipid antibodies…”
Get full text

Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies by de Larrañaga, G, Forastiero, R, Carreras, L O, Zala, N, Guzman, L, Alonso, B

Get more information

P343 Levels of the anticoagulant and anti-inflammatory protein S (PROS1) in patients with inflammatory bowel disease (IBD) relationship with disease activity, IBD disease patterns, and C4-binding protein (C4BP) by Sambuelli, A, Chavero, P, de Larrañaga, G, Errasti, A, Peres, S, Tessone, L, Negreira, S, Silvia, N, Bellicoso, M, Huernos, S, Goncalves, S, Tirado, P, Carrera Silva, E A, Rothlin, C

“…Abstract Background Inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn’s disease (CD) show an increased risk of thrombosis. PROS1 is a…”
Get full text

P074 Decreased levels of circulating protein S (PROS1) in patients with active Crohn's disease by Sambuelli, A., Chavero, P., de Larrañaga, G., Errasti, A., Carrera Silva, A., Tessone, L., Peres, S., Negreira, S., Gil, A., Bellicoso, M., Goncalves, S., Huernos, S., Tirado, P., Rothlin, C.

Get full text

Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases by de Larrañaga, G F, Harris, N, Pierangeli, S S, Alonso, B S, Schroder, T, Fainboim, H

“…Antiphospholipid antibodies (aPL) have been associated with different diseases. They are defined as a large family of immunoglobulins (Ig) of either…”
Get more information